Akebia Therapeutics
AKBA
AKBA
139 hedge funds and large institutions have $399M invested in Akebia Therapeutics in 2021 Q2 according to their latest regulatory filings, with 17 funds opening new positions, 53 increasing their positions, 39 reducing their positions, and 21 closing their positions.
Holders
139
Holders Change
-5
Holders Change %
-3.47%
% of All Funds
2.43%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.02%
New
17
Increased
53
Reduced
39
Closed
21
Calls
$2.3M
Puts
$3.77M
Net Calls
-$1.47M
Net Calls Change
-$37K
Top Buyers
| 1 |
1
Marshall Wace
London,
United Kingdom
|
$15.6M |
| 2 |
2
JPMorgan Chase & Co
New York
|
$18.8M |
| 3 |
3
Federated Hermes
Pittsburgh,
Pennsylvania
|
$7.14M |
| 4 |
4
Dimensional Fund Advisors
Austin,
Texas
|
$12.9M |
| 5 |
5
BlackRock
New York
|
$49.9M |
Top Sellers
| 1 |
1
State Street
Boston,
Massachusetts
|
$53.1M |
| 2 |
2
Millennium Management
New York
|
$1M |
| 3 |
3
Morgan Stanley
New York
|
$10.1M |
| 4 |
4
Two Sigma Advisers
New York
|
$1.36M |
| 5 |
5
Two Sigma Investments
New York
|
$0 |
